
Press releases
21st Nov 2022
genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces its audited...
5th Oct 2022
Genedrive file US FDA Pre-Submission for the Genedrive® MT-RNR1 Product Range
genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that it has...
26th Sep 2022
NICE to accelerate evaluation of the Genedrive® MT-RNR1 Test
genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that the UK...